Quality of Life and Eating Disorders in Children With FPIES, Food Allergy or Celiac Disease
QUALIM
Evaluation of Quality of Life and Eating Disorders in Children With Food Protein Induced Enterocolitis Syndrom, Food Allergy or Celiac Disease
QUALIM
Evaluation of Quality of Life and Eating Disorders in Children With Food Protein Induced Enterocolitis Syndrom, Food Allergy or Celiac Disease
Sponsor study identifier
Secondary identifiers
OTHER · ANSM
observational
403
1 country
1
Study Start
January 5, 2021
Actual (reported)Primary Completion
July 22, 2022
Actual (reported)Study Completion
July 22, 2022
Actual (reported)Food allergies are associated with a decrease in quality of life. Patients with FPIES often have more food avoidance than necessary. The greater the number of avoided foods, the greater the risk of eating disorders. To date, no study about quality of life or assessment of eating difficulties has been performed in a French-speaking pediatric population with FPIES or celiac disease
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 22, 2022
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 19, 2020
Actual (reported)November 25, 2020
Actual (reported)January 5, 2021
Actual (reported)July 22, 2022
Actual (reported)July 22, 2022
Actual (reported)Quality of life (QoL) in children with FPIES
FAQLQ (Food Allergy Quality of Life Questionnaire)-PF (Parent form) for parents of children from 0 to 12 years old with FPIES FAQLQ-CF (Child Form) for children between 8 to 12 years old with FPIES PedsQLTM: generic questionnaire of QoL for parents and children from 0 to 12 years old with FPIES
12 months
Food neophobia in children with FPIES
24 months
QoL in children with food allergy
24 months
100 patients
100 patients
100 patients
100 patients
Patients recruited from hospitalization (conventional, and day-care unit) and consultation. Healthy controls without any food avoidance recruited from consultations, hospitalisations or community. Multicentric study * Pediatric Nutrition and Gastroenterology Unit - Trousseau Hospital, APHP; * Pediatric Pneumology and Allergy Unit - Necker-Enfants Malades Hospital, APHP; * Pediatric department and Asthma and Allergy unit - Ambroise Paré Hospital, APHP.
Trousseau Hospital, Service : Nutrition et Gastroentérologie Pédiatrique
Paris, France
Anaïs Lemoine
Assistance Publique - Hôpitaux de Paris
403 participants (actual enrollment reported by the registry).
First Submitted
November 19, 2020
First Posted
November 25, 2020
Study Start
January 5, 2021
Actual (reported)A Study of Guselkumab in Adult Participants With Celiac Disease
QoL in children with celiac disease
24 months
QoL in children without any food avoidance
24 months
Food neophobia in children with food allergy
24 months
Contact the study team to confirm eligibility.
Primary Completion
July 22, 2022
Actual (reported)Study Completion
July 22, 2022
Actual (reported)Last Updated
September 28, 2022
Record last verified: 2022-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: